
The significance of pretreatment anemia in the era of R‐IPI and NCCN‐IPI prognostic risk assessment tools: a dual‐center study in diffuse large B‐cell lymphoma patients
Anemia is frequently identified at the time of diagnosis in patients with diffuse large B‐cell lymphoma (DLBCL); however, studies addressing the prognostic significance of this important clinical parameter are lacking.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics
Keywords: diffuse large B‐cell lymphoma; hemoglobin; prognostic factors
Document Type: Research Article
Publication date: December 1, 2015